Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Bisphosphonates can improve bone mineral density in renal transplant recipients

Nature Clinical Practice Nephrology volume 2, pages 676–677 (2006)Cite this article

boxed-textMitterbauer C et al. (2006) Effects of bisphosphonates on bone loss in the first year after renal transplantation—a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 21: 2275–2281

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Coco M et al. (2003) Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 14: 2669–2676

    Article  CAS  Google Scholar 

  2. Ettinger B et al. (2004) Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. J Bone Miner Res 19: 745–751

    Article  CAS  Google Scholar 

  3. Schwarz C et al. (2004) Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation. Kidney Int 65: 304–309

    Article  CAS  Google Scholar 

  4. Bamias A et al. (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23: 8580–8587

    Article  Google Scholar 

  5. Vautour LM et al. (2004) Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 15: 160–167

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Division of Nephrology and Clinical Immunology at the University Hospital Aachen, Aachen, Germany

    Ralf Westenfeld, Vincent M Brandenburg & Markus Ketteler

Authors
  1. Ralf Westenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincent M Brandenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Markus Ketteler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Markus Ketteler.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Westenfeld, R., Brandenburg, V. & Ketteler, M. Bisphosphonates can improve bone mineral density in renal transplant recipients. Nat Rev Nephrol 2, 676–677 (2006). https://doi.org/10.1038/ncpneph0334

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0334

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing